ReviewFrontiers in public health2026
Climate change, environmental exposures, and breast cancer: advancing climate-resilient oncology through sustainable development goal 13.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Climate change is increasingly recognized as a major determinant of human health, yet its implications for breast cancer prevention, progression, and healthcare delivery remain insufficiently integrated into global cancer control strategies. Breast cancer, the most commonly diagnosed malignancy among women worldwide, is influenced by a complex interplay of genetic, hormonal, environmental, and socioeconomic factors, many of which are being reshaped by climate change. This narrative review examines the intersections between climate change, environmental exposures, and breast cancer within the framework of the United Nations Sustainable Development Goal 13 (Climate Action). Current evidence indicates that climate-driven environmental changes-including worsening air pollution, wildfire emissions, endocrine-disrupting chemicals, pesticide exposure, water contamination, and food system disruptions-may contribute to breast carcinogenesis through mechanisms involving oxidative stress, chronic inflammation, immune dysregulation, endocrine perturbation, and epigenetic modification. The review further highlights that susceptibility may differ across molecular subtypes, with endocrine-disrupting chemicals having greater relevance to hormone receptor-positive disease, while inflammatory and immune-mediated pathways may influence more aggressive phenotypes, although subtype-specific evidence remains limited. Beyond biological mechanisms, climate-related disasters disrupt breast cancer screening, diagnosis, treatment continuity, and survivorship care, disproportionately affecting socioeconomically disadvantaged populations through interactions with established determinants of health, including healthcare access, lifestyle factors, and structural inequities. The review critically evaluates the current alignment between SDG 13 and breast cancer control, identifying important gaps in the integration of oncology into national climate adaptation policies while highlighting opportunities for climate-resilient health systems, green oncology, exposomics, artificial intelligence, and precision environmental health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.